-+ 0.00%
-+ 0.00%
-+ 0.00%

SATELLOS ANNOUNCES COMPLETION OF ENROLLMENT IN BASECAMP PHASE 2 CLINICAL TRIAL OF FORAZAPADIN FOR DUCHENNE MUSCULAR DYSTROPHY

Reuters·09/30/2026 11:00:02

Please log in to view news